Regenerative Medical Technology Group Inc.
RMTG
$0.09
$0.00-4.44%
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -167.00% | 37.08% | 68.01% | -201.59% | -89.95% |
| Total Depreciation and Amortization | -7.06% | -0.61% | 29.17% | 38.87% | 5.79% |
| Total Amortization of Deferred Charges | -52.72% | -7.61% | 52.39% | 795.34% | -- |
| Total Other Non-Cash Items | 188.10% | -20.74% | -315.40% | 201.08% | 12,490.91% |
| Change in Net Operating Assets | 3.63% | -14.27% | -54.09% | 428.10% | -22.23% |
| Cash from Operations | 225.17% | 167.28% | 118.75% | 65.94% | -1,147.46% |
| Capital Expenditure | 86.21% | -18.04% | -18.86% | -103.25% | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 86.21% | -18.04% | -18.86% | -103.25% | -- |
| Total Debt Issued | -108.36% | -- | -- | -100.00% | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -108.36% | -- | -- | -100.00% | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 150.14% | 145.72% | 46.57% | -209.53% | 585.29% |